Financial Data and Key Metrics Changes - The partnership reported adjusted EBITDA of $458 million and distributable cash flow as adjusted of $310 million for Q1 2025, with a strong balance sheet and liquidity [6][9] - The leverage ratio at the end of the quarter was 4.1 times, aligning with the long-term target [7] - A distribution of $0.08 per common unit was declared, representing an increase of just over 1.25% compared to the previous quarter, with a trailing twelve-month coverage ratio of 1.9 times [8][9] Business Line Data and Key Metrics Changes - Fuel Distribution segment adjusted EBITDA was $220 million, with volumes at 2.1 billion gallons, down 3% from the previous quarter but flat year-over-year [12] - Pipeline Systems segment reported adjusted EBITDA of $172 million, with throughput at approximately 1.3 million barrels per day, down from 1.4 million barrels per day in the previous quarter [13] - Terminals segment delivered adjusted EBITDA of $66 million, with throughput increasing to 620,000 barrels per day from around 600,000 barrels per day in the previous quarter [14] Market Data and Key Metrics Changes - The company is expanding its geographic reach through acquisitions, including Parkland Corporation and Tankwit, which will enhance its presence in North America and Europe [4][8][15] - The acquisition of Tankwit, Germany's largest independent storage operator, is expected to close in the second half of 2025 and will be accretive to unitholders in the first year [7][8] Company Strategy and Development Direction - The company aims for an annual distribution growth rate of at least 5%, having increased distributions by approximately 9% since 2022 [9] - The strategy focuses on fuel profit optimization and integration with midstream assets, leveraging existing infrastructure for growth [15][18] - The company emphasizes strong operational execution, expense discipline, and profit optimization to deliver strong returns on capital [18][23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year 2025 guidance despite potential challenges from inflation and recession [20][22] - The business model is designed to perform well in volatile environments, supported by pipeline and terminal assets that provide stable income [21][22] - The company is proactively managing expenses to remain below operating expense guidance, ensuring continued growth and value creation [23] Other Important Information - The company completed a $1 billion offering of senior notes to improve financial flexibility and extend debt maturity [6][7] - The acquisition of Parkland Corporation is valued at approximately $9.1 billion and is expected to close in the second half of 2025 [4][8] Q&A Session Summary Question: Future capital allocation among regions post Parkland close - Management indicated that capital allocation is evaluated across all segments and geographies, focusing on the best projects rather than specific regional targets [26][27] Question: Right mix between fuel distribution and conventional midstream assets - Management stated that while the portfolio may not always be perfectly balanced, the goal is to maintain a diversified portfolio, with a focus on long-term strength [28][29]

Financial Data and Key Metrics Changes - Total revenues for Q1 2025 were $99 million, reflecting a 4% increase compared to Q1 2024 [20] - Adjusted EBITDA increased approximately 1% from $17.3 million to $17.5 million in Q1 2025 [20] - Adjusted EBITDA margin was 17.7%, relatively flat compared to the previous year [21] - Gross margins decreased to 64.2% from 64.6% year over year due to lower revenue from higher margin products [22] Business Line Data and Key Metrics Changes - Strength graft revenues grew 19% on a constant currency basis in Q1 2025 [8] - On X revenue increased by 11% year over year on a constant currency basis [11] - BioGlue revenues grew 9% on a constant currency basis [12] - Tissue processing revenues declined 23% year over year due to the backlog caused by a cybersecurity incident [12] Market Data and Key Metrics Changes - Latin America and Asia Pacific saw constant currency revenue growth of 268% and 14% respectively in Q1 2025 [13] - North America revenues declined by 6% compared to Q1 2024 [21] - EMEA revenues increased by 14% year over year [21] Company Strategy and Development Direction - The company is focused on ramping up On X supply and clearing the tissue processing backlog, with expectations to be fully caught up by the end of Q3 2025 [7][13] - The ongoing launch of AMDS in the U.S. is a key growth driver, with approximately 150 facilities actively seeking approvals [10][11] - The company aims to leverage positive clinical data to expand market share for On X valves, particularly among younger patients [12][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving double-digit revenue growth and twice that rate for EBITDA in the future [19][29] - The company raised its full-year 2025 revenue guidance to a constant currency growth range of 11% to 14% [24] - Management noted that the impact of the cybersecurity incident is being resolved, with expectations for a return to normalcy in operations [6][29] Other Important Information - The company incurred approximately $4.7 million in Q1 related to the cybersecurity incident, which is excluded from adjusted EBITDA [22] - The net leverage ratio improved to 4.0 from 4.5 year over year [24] - The company does not anticipate the need to raise additional capital to fund its operations in the foreseeable future [22] Q&A Session Summary Question: Contribution of AMDS to growth and onboarding of facilities - Management indicated that AMDS contributed to the strong growth but did not break out specific numbers. They are encouraged by the reception from the clinical community and the onboarding process is progressing well [36][38] Question: Expectations for tissue growth recovery - Management expects to return to mid-single-digit growth for tissue processing by the end of the year, with the backlog being cleared in Q2 and Q3 [40][42] Question: Cash flow expectations for the year - Management expects to be free cash flow positive for the year, despite Q1 being seasonally high in expenses [54][56] Question: Growth rates for On X and stent grafts - Management expects On X to continue double-digit growth and stent grafts to grow at a mid-teens rate, with AMDS expected to improve overall growth rates [64][66] Question: Timing for acquiring Endospan - The option to acquire Endospan will trigger upon FDA approval, expected in the second half of 2026, with a decision required within 90 days of approval [72][74] Question: Feedback on Nexus data and market opportunity - Management expressed optimism about the Nexus data and its potential market impact, noting that the mortality benefits could lead to increased adoption [80][82]

Financial Data and Key Metrics Changes - For Q4 2024, the company reported revenues of approximately $169 million, a decrease of 2% compared to Q4 2023, and adjusted EBITDA of approximately $18 million, down 18% year-over-year [21] - For the full year 2024, adjusted revenues were approximately $563 million, a decrease of about 3% from 2023, with adjusted EBITDA at $42 million compared to $53 million in the prior period [22][23] Business Line Data and Key Metrics Changes - The company is focusing on improving its balance sheet, reporting inventories at approximately $180 million, which included write-downs for obsolescence and slow-moving items [22] - The average inventory turns for 2024 ended at 1.67%, with a target to push this metric towards about 2 turns by year-end 2025 [24] Market Data and Key Metrics Changes - The agricultural economy is showing signs of gradual improvement, with customers indicating a slight improvement in sentiment since the low point in summer 2024, although they remain conservative in buying patterns [16] - The company anticipates that 2025 will be better than 2024, with an adjusted EBITDA target range of $45 million to $52 million and expected sales between $565 million and $585 million [18] Company Strategy and Development Direction - The new CEO emphasized the need to improve margins, rightsize the balance sheet, and return to growth, with a focus on simplifying operations and prioritizing key tasks [9][14] - The company plans to allocate the bulk of its free cash flow towards debt repayment as part of its transformation strategy [19] Management's Comments on Operating Environment and Future Outlook - Management noted that while the agricultural economy is improving, farmers are cautious due to high capital costs and potential tariffs, leading to a just-in-time purchasing approach [16][53] - The CEO expressed confidence that 2025 will show improvement over 2024, contingent on resolving tariff issues and improving market conditions [54] Other Important Information - The company recorded $118 million in nonrecurring charges for 2024, primarily related to asset impairments and transformation projects [27] - There is a delay in filing the audited 10-K due to complex assessments related to write-downs, with plans to file a 12b-25 with the SEC [29] Q&A Session Summary Question: Timing of the financial filing - Management indicated that the filing would occur within weeks, not months, and the delay was due to complex write-down assessments rather than any surprising issues [40][41] Question: Working capital expectations for 2025 - The focus remains on inventory as the primary area for working capital improvement, with a refreshed SIOP model to enhance efficiency [45] Question: Addressing organizational complexity - The CEO discussed steps taken to simplify the organization, including an ERP system implementation and restructuring for accountability [47][48] Question: Impact of tariffs on farmer buying patterns - Management noted that uncertainty from tariffs is causing farmers to be cautious, affecting their purchasing decisions [53] Question: Confidence in 2025 guidance - The CEO expressed confidence in the guidance, with the lower end reflecting slower industry conditions and the upper end reflecting positive influences on purchasing [69] Question: Transformation costs for 2025 - Projected transformation costs for 2025 are around $5 million, significantly lower than in 2024, with expected benefits from commercial activities and logistics [72]

Financial Data and Key Metrics Changes - In Q4 2024, adjusted EBITDA was reported at $237 million, with distributable cash flow of $155 million and free cash flow of $32 million [16] - For the full year 2024, adjusted EBITDA reached $971 million, representing a 16% year-over-year increase, and an 18% increase when normalizing for November impacts [11][19] - Capital expenditures for 2024 totaled $265 million, which was approximately $15 million below the midpoint of the guidance range [11][19] Business Line Data and Key Metrics Changes - The Midstream Logistics segment generated adjusted EBITDA of $150 million in Q4, up 3% year-over-year but down 14% sequentially due to negative Waha prices [16][17] - The Pipeline Transportation segment reported adjusted EBITDA of $92 million, up nearly 9% year-over-year, driven by volume growth and contributions from EPIC Crude [18] Market Data and Key Metrics Changes - Average gas processed volumes for 2024 were 1.64 billion cubic feet per day, up 13% year-over-year [10] - The average gas daily price at Waha was negative $1.4 per MMBtu for the first half of November, impacting volumes and margins [16][17] Company Strategy and Development Direction - The company aims for a 10% compound annual growth rate (CAGR) in EBITDA over the next five years, focusing on both organic growth and strategic M&A opportunities [26][40] - Kinetic is positioned to capitalize on the growing demand for natural gas and liquids, with significant growth expected in the Permian Basin and Gulf Coast [12][13] - The company is exploring a large-scale gas-fired power generation facility to manage electricity costs and capitalize on natural gas price volatility [14][80] Management's Comments on Operating Environment and Future Outlook - Management noted that 2024 was transformational, with significant M&A activity and organic growth, particularly in the Delaware Basin [6][9] - The company has implemented new risk measures to prevent operational headwinds experienced in November and expects a strong rebound in operational performance [10][17] - Management expressed confidence in achieving a 15% growth in adjusted EBITDA for 2025, with key assumptions including a 20% growth in gas processed volumes [19][21] Other Important Information - The company increased its cash dividend by 4%, marking the first return of capital to shareholders since its merger [9] - Kinetic's leverage ratio improved to 3.4 times, down 0.6 times year-over-year, reflecting disciplined capital management [19][24] Q&A Session Summary Question: What infrastructure is needed to achieve the 10% EBITDA CAGR? - Management indicated that they are seeing outsized market share performance and have structural changes that will create incremental EBITDA opportunities [26][27] Question: Are there still M&A opportunities in 2025? - Management confirmed that opportunities remain, but they maintain a high bar for attractiveness in potential transactions [32][33] Question: What are the expectations for producer customer activity in 2025? - Management noted robust activity levels across both Northern and Southern Delaware, with significant drilling capital being allocated to New Mexico [45][46] Question: How does the company manage risks associated with pipeline maintenance? - Management acknowledged the regular seasonal maintenance and emphasized the importance of having incremental length for Gulf Coast capacity to mitigate risks [51][54] Question: Can you clarify the economic contribution of the Barilla Draw acquisition? - Management stated that the initial phase involves gas gathering services, with processing expected to ramp up later in the decade, contributing to margin expansion [98] Question: What is the timeline for the power generation project? - Management indicated that if the project reaches FID this year, it could be operational by the end of 2027, with potential for further projects in New Mexico [100][102]

Financial Data and Key Metrics Changes - The company reported approximately $107 million in quarterly adjusted EBITDA for Q4 2024, an increase from $100.9 million in the same period of 2023, representing a growth of about 1.1% [4][11] - Distributable cash flow (DCF) as adjusted was $69.5 million, with a DCF coverage ratio of approximately 1.2 times, expected to return to a long-term objective of 1.3 times in the second half of 2025 [11] - The company initiated a strong 2025 EBITDA guidance of $480 million to $520 million, indicating around 20% growth over 2024 adjusted EBITDA [8] Business Line Data and Key Metrics Changes - Gathering and Processing segment adjusted EBITDA for Q4 was $66 million, up from $53.3 million in Q4 2023, primarily due to higher throughput from Permian Basin assets and contributions from H2O Midstream [11][12] - Wholesale marketing and tourmaline adjusted EBITDA decreased to $21.2 million from $28.4 million in the prior year, attributed to lower wholesale margins and intercompany transaction impacts [12] - Storage and transportation adjusted EBITDA increased slightly to $17.8 million from $17.5 million in Q4 2023, driven by higher storage and transportation rates [12] - Investments in Pipeline Joint Ventures contributed $11.3 million this quarter, compared to $8.5 million in Q4 2023, mainly due to contributions from the Wink to Webster drop down [13] Market Data and Key Metrics Changes - The company is focusing on becoming a premier full-service provider in the Pearland Basin and has made significant acquisitions in the Midland Basin, enhancing its competitive position [4][6] - The expansion of the processing plant in the Delaware Basin is on track to complete on time and on budget in the first half of 2025, indicating strong market demand [6][7] Company Strategy and Development Direction - The company aims to enhance its economic separation from its sponsor, DK, and has authorized a $150 million buyback program to increase value for DKL unitholders [8][9] - The company is committed to prudent management of leverage and coverage while pursuing organic growth projects [10][11] - The strategic focus includes expanding offerings in crude, natural gas, and water services, which has proven beneficial in the Delaware Basin [32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the guidance provided, highlighting the importance of economic separation from DK to fulfill DKL's potential [18][21] - The management noted strong demand for assets in the Delaware area and emphasized the comprehensive offering of services as a competitive advantage [32][33] Other Important Information - The capital program for Q4 was $49.4 million, with $42.1 million allocated to the new gas processing plant and the remainder for growth projects [13][14] - The company expects to spend approximately $75 million on completing the Libby processing plant expansion and $160 million on growth and maintenance projects in 2025 [14] Q&A Session Summary Question: Inquiry about EBITDA guidance and factors influencing high and low ends - Management acknowledged the conservative nature of the guidance and emphasized the company's growth trajectory and economic separation efforts [17][18] Question: Follow-up on the buyback program execution and funding - Management indicated that the buyback program is a two-year initiative, with funding potentially coming from free cash flow or debt, depending on market conditions [20][23] Question: Request for additional drivers behind EBITDA upside potential - Management highlighted several completed transactions and synergies from recent acquisitions as key drivers for the expected EBITDA growth [29][30] Question: Inquiry about demand and utilization of key assets - Management confirmed strong demand in the Delaware area and the strategic decision to expand assets based on this demand [32][33]